This inventor holds 2 USPTO granted patents. Top assignee: Astrazeneca Ab. Active years: 2021-2025.
Company Filing History:
Years Active: 2021-2025
Title: Himjyot Jaiswal: Innovator in Cell Genome Modification
Introduction
Himjyot Jaiswal is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of biotechnology, particularly in the area of cell genome modification. With a total of 2 patents to his name, Jaiswal is recognized for his innovative approaches and methodologies.
Latest Patents
One of his latest patents is titled "Inducible Modification of a Cell Genome." This patent focuses on compositions and methods for the inducible modification of a cell genome. The work aims to enhance the precision and efficiency of genetic modifications, which can have far-reaching implications in various fields, including medicine and agriculture.
Career Highlights
Himjyot Jaiswal is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca allows him to collaborate with other experts in the field and contribute to groundbreaking research and development projects.
Collaborations
Throughout his career, Jaiswal has worked alongside esteemed colleagues such as Lorenz M Mayr and Xiufeng Xu. These collaborations have further enriched his research and have led to advancements in the understanding of cell genome modifications.
Conclusion
Himjyot Jaiswal is a prominent figure in the field of biotechnology, with a focus on cell genome modification. His innovative patents and collaborations highlight his commitment to advancing scientific knowledge and technology.